-
Ruxolitinib
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Ruxolitinib Myelofibrosis Novartis Lub Xya Hli 6, 2024 -
Crisaborole
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Crisaborole Atopic Dermatitis thiab Eczema Pfizer Lub Rau Hli 11, 2026 -
Relugolix
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Relugolix Prostatic mob qog noj ntshav Takeda thiab ASKA Peb Hlis 24, 2024 -
Vericiguat
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Vericiguat Lub plawv tsis ua hauj lwm Bayer thiab MSD Tsib.Peb 24, 2031 -
Abrocitinib
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Abrocitinib Atopic dermatitis Pfizer Peb 11, 2034 -
Rimeegept
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Rimeegept Migraine mob taub hau Biohaven Lub Ob Hlis 22, 2031 -
Elagolix 834153-87-6
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP ElagolixCAS:834153-87-6 Endometriosis Hauv tsev -
Relugolix 737789-87-6
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Ribociclib CAS Nr .: 737789-87-6 Antineoplastic Hauv tsev -
Venetoclax 1257044-40-8
API lub npe Qhov taw qhia Innovator Patent Expiry Date (Tebchaws Asmeskas) Venetoclax 1257044-40-8 CLL Abbvie Lub Rau Hli 27, 2031 -
Velpatasvir (PVP)
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Velpatasvir (PVP) HCV Hauv tsev √ -
Thalidomide
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Thalidomide Oncology tshuaj USP/EP -
Ticagrelor
API lub npe Qhov taw qhia Specification US DMF EU DMF CEP Ticagrelor Anticoagulant Hauv tsev 28984 ib √
